Author:
Shi Jia,Tang Mingwei,Zhou Shuang,Xu Dong,Zhao Jiuliang,Wu Chanyuan,Wang Qian,Tian Xinping,Li Mengtao,Zeng Xiaofeng
Abstract
Idiopathic inflammatory myopathy (IIM) is a heterogeneous group of acquired, autoimmune muscle diseases characterized by muscle inflammation and extramuscular involvements. Present literatures have revealed that dysregulated cell death in combination with impaired elimination of dead cells contribute to the release of autoantigens, damage-associated molecular patterns (DAMPs) and inflammatory cytokines, and result in immune responses and tissue damages in autoimmune diseases, including IIMs. This review summarizes the roles of various forms of programmed cell death pathways in the pathogenesis of IIMs and provides evidence for potential therapeutic targets.
Funder
Beijing Municipal Science and Technology Commission
National Natural Science Foundation of China
Subject
Immunology,Immunology and Allergy
Reference126 articles.
1. Classification of Myositis;Lundberg;Nat Rev Rheumatol,2018
2. One Year in Review 2020: Idiopathic Inflammatory Myopathies;Zanframundo;Clin Exp Rheumatol,2020
3. Autoantibodies in Myositis;McHugh;Nat Rev Rheumatol,2018
4. Dermatomyositis and Type 1 Interferons;Greenberg;Curr Rheumatol Rep,2010
5. Regulated Necrosis: The Expanding Network of non-Apoptotic Cell Death Pathways;Vanden Berghe;Nat Rev Mol Cell Biol,2014
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献